Home Other Building Blocks Gw274150

Gw274150

CAS No.:
210354-22-6
Catalog Number:
AG00BC19
Molecular Formula:
C8H17N3O2S
Molecular Weight:
219.3045
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
1 week
United States
$473
- +
10mg
1 week
United States
$682
- +
25mg
1 week
United States
$1029
- +
50mg
1 week
United States
$1446
- +
100mg
1 week
United States
$2140
- +
Product Description
Catalog Number:
AG00BC19
Chemical Name:
Gw274150
CAS Number:
210354-22-6
Molecular Formula:
C8H17N3O2S
Molecular Weight:
219.3045
MDL Number:
MFCD07363946
IUPAC Name:
(2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid
InChI:
InChI=1S/C8H17N3O2S/c1-6(9)11-3-5-14-4-2-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1
InChI Key:
MOLOJNHYNHBPCW-ZETCQYMHSA-N
SMILES:
CC(=NCCSCCC(C(=O)O)N)N
UNII:
0ZZF1V8G63
Properties
Complexity:
209  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
219.104g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
219.303g/mol
Monoisotopic Mass:
219.104g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
127A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.3  
Literature
Title Journal
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors. Current treatment options in neurology 20120201
Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis. Clinical and experimental rheumatology 20120101
Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase. Molecular and cellular biochemistry 20111201
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights. Bioorganic & medicinal chemistry letters 20110715
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Bioorganic & medicinal chemistry letters 20110515
Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease. Free radical biology & medicine 20110301
Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia : an international journal of headache 20101201
Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochemical Society transactions 20090801
Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. American journal of respiratory and critical care medicine 20071115
y+ LAT-1 mediates transport of the potent and selective iNOS inhibitor, GW274150, in control J774 macrophages. Amino acids 20060901
An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models. European journal of pain (London, England) 20060801
Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Critical care medicine 20060201
GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 20060101
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. British journal of pharmacology 20050601
Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. European journal of pharmacology 20050110
Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respiratory research 20050101
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution. Journal of medicinal chemistry 20040603
Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation. British journal of pharmacology 20040301
GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells. Medical science monitor : international medical journal of experimental and clinical research 20031001
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney international 20030301
A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20021201
Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. European journal of pharmacology 20021018
NOS-II is involved in early differentiation of murine cortical, retinal and ES cell-derived neurons-an immunocytochemical and functional approach. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20020401
Nitric oxide synthases: structure, function and inhibition. The Biochemical journal 20010801
Inhibitors of nitric oxide synthase in inflammatory arthritis. IDrugs : the investigational drugs journal 19980701
Properties